Published in Gene Therapy Weekly, November 22nd, 2001
The Phase I/II trial was conducted at three medical centers under the direction of Eric Small, MD, clinical professor of medicine and urology at the University of California, San Francisco, Comprehensive Cancer Center. These data were reported at the European Cancer Conference (ECCO) being held in Lisbon, Portugal.
The Phase I/II study was a dose trial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.